Empagliflozin-Induced Acute Pancreatitis and Euglycemic Diabetic Ketoacidosis in Type 2 Diabetes Mellitus. Am. J. Chem. Pharm. [Internet]. 2022 Oct. 23 [cited 2026 Aug. 2];1(2):1-4. Available from: https://www.e-pallipublishers.com/index.php/ajcp/article/view/747